SEC Form 4 · accession 0001562180-17-001134
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Feb 17, 2017
Accepted (ET)
Mar 7, 2017 · 9:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 17, 2017 | F | 86 | $83.13 | D | 17,605 | D |
Table II — derivative securities
No Table II lines on this filing.